Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.
Critère d'inclusion
- Medical abortion